Cite
Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease
MLA
Ezequiel Ridruejo, et al. “Efficacy and Safety of Direct-Acting Antiviral Agents for HCV in Mild-to-Moderate Chronic Kidney Disease.” Nefrología (English Edition), vol. 40, no. 1, Jan. 2020, pp. 46–52. EBSCOhost, https://doi.org/10.1016/j.nefroe.2019.03.014.
APA
Ezequiel Ridruejo, Rebeca Garcia-Agudo, Manuel Mendizabal, Sami Aoufi-Rabih, Vivek Dixit, Marcelo Silva, & Fabrizio Fabrizi. (2020). Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease. Nefrología (English Edition), 40(1), 46–52. https://doi.org/10.1016/j.nefroe.2019.03.014
Chicago
Ezequiel Ridruejo, Rebeca Garcia-Agudo, Manuel Mendizabal, Sami Aoufi-Rabih, Vivek Dixit, Marcelo Silva, and Fabrizio Fabrizi. 2020. “Efficacy and Safety of Direct-Acting Antiviral Agents for HCV in Mild-to-Moderate Chronic Kidney Disease.” Nefrología (English Edition) 40 (1): 46–52. doi:10.1016/j.nefroe.2019.03.014.